{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:15:34Z","timestamp":1793121334245,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2024C03007"],"award-info":[{"award-number":["2024C03007"]}],"id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"DOI":"10.1186\/s10194-025-02243-5","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T10:46:57Z","timestamp":1766400417000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effectiveness of rimegepant in vestibular migraine: a prospective self-controlled cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Jinyan","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zewei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengna","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"2243_CR1","doi-asserted-by":"crossref","unstructured":"Espinosa-Sanchez JM, Lin C-C (2025) Editorial: vestibular migraine. Front Neurol Volume 16\u20132025","DOI":"10.3389\/fneur.2025.1587097"},{"key":"2243_CR2","unstructured":"(2018) Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38:1-211"},{"key":"2243_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/VES-201644","volume":"32","author":"T Lempert","year":"2022","unstructured":"Lempert T, Olesen J, Furman J et al (2022) Vestibular migraine: diagnostic criteria1. J Vestib Res 32:1\u20136","journal-title":"J Vestib Res"},{"key":"2243_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/VES-2009-0343","volume":"19","author":"A Bisdorff","year":"2009","unstructured":"Bisdorff A, Von Brevern M, Lempert T et al (2009) Classification of vestibular symptoms: towards an international classification of vestibular disorders. J Vestib Res 19:1\u201313","journal-title":"J Vestib Res"},{"key":"2243_CR5","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1212\/01.wnl.0000237539.09942.06","volume":"67","author":"HK Neuhauser","year":"2006","unstructured":"Neuhauser HK, Radtke A, von Brevern M et al (2006) Migrainous vertigo: prevalence and impact on quality of life. Neurology 67:1028\u20131033","journal-title":"Neurology"},{"key":"2243_CR6","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1097\/MAO.0000000000001900","volume":"39","author":"EJ Formeister","year":"2018","unstructured":"Formeister EJ, Rizk HG, Kohn MA et al (2018) The epidemiology of vestibular migraine: A Population-based survey study. Otol Neurotol 39:1037\u20131044","journal-title":"Otol Neurotol"},{"key":"2243_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1055\/s-0039-3402735","volume":"40","author":"RW Baloh","year":"2020","unstructured":"Baloh RW (2020) Vestibular migraine I: Mechanisms, Diagnosis, and clinical features. Semin Neurol 40:76\u201382","journal-title":"Semin Neurol"},{"key":"2243_CR8","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1007\/s00415-023-12166-3","volume":"271","author":"Y Xing","year":"2024","unstructured":"Xing Y, Si L, Zhang W et al (2024) Etiologic distribution of dizziness\/vertigo in a neurological outpatient clinic according to the criteria of the international classification of vestibular disorders: a single-center study. J Neurol 271:2446\u20132457","journal-title":"J Neurol"},{"key":"2243_CR9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s10194-024-01873-5","volume":"25","author":"Z Yang","year":"2024","unstructured":"Yang Z, Wang X, Niu M et al (2024) First real-world study on the effectiveness and tolerability of Rimegepant for acute migraine therapy in Chinese patients. J Headache Pain 25:160","journal-title":"J Headache Pain"},{"key":"2243_CR10","doi-asserted-by":"publisher","first-page":"e2128544","DOI":"10.1001\/jamanetworkopen.2021.28544","volume":"4","author":"CP Yang","year":"2021","unstructured":"Yang CP, Liang CS, Chang CM et al (2021) Comparison of new Pharmacologic agents with triptans for treatment of migraine: A systematic review and Meta-analysis. JAMA Netw Open 4:e2128544","journal-title":"JAMA Netw Open"},{"key":"2243_CR11","first-page":"3591","volume":"26","author":"Association TVCotCME","year":"2023","unstructured":"Association TVCotCME (2023) Expert consensus on betahistine mesylate in the treatment of vertigo. Chin Gen Pract 26:3591\u20133598","journal-title":"Chin Gen Pract"},{"key":"2243_CR12","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S0140-6736(23)01049-8","volume":"402","author":"P Pozo-Rosich","year":"2023","unstructured":"Pozo-Rosich P, Ailani J, Ashina M et al (2023) Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 402:775\u2013785","journal-title":"Lancet"},{"key":"2243_CR13","first-page":"350","volume":"18","author":"P Bikhazi","year":"1997","unstructured":"Bikhazi P, Jackson C, Ruckenstein MJ (1997) Efficacy of antimigrainous therapy in the treatment of migraine-associated Dizziness. Am J Otol 18:350\u2013354","journal-title":"Am J Otol"},{"key":"2243_CR14","doi-asserted-by":"crossref","unstructured":"Iwasaki S, Ushio M, Chihara Y et al (2007) Migraine-associated vertigo: clinical characteristics of Japanese patients and effect of lomerizine, a calcium channel antagonist. Acta Otolaryngol Suppl:45\u201349","DOI":"10.1080\/03655230701596491"},{"key":"2243_CR15","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/WCO.0000000000001257","volume":"37","author":"MD Villar-Martinez","year":"2024","unstructured":"Villar-Martinez MD, Goadsby PJ (2024) Vestibular migraine: an update. Curr Opin Neurol 37:252\u2013263","journal-title":"Curr Opin Neurol"},{"key":"2243_CR16","first-page":"Cd015322","volume":"4","author":"KE Webster","year":"2023","unstructured":"Webster KE, Dor A, Galbraith K et al (2023) Pharmacological interventions for acute attacks of vestibular migraine. Cochrane Database Syst Rev 4:Cd015322","journal-title":"Cochrane Database Syst Rev"},{"key":"2243_CR17","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1186\/s13063-019-3903-5","volume":"20","author":"O Bayer","year":"2019","unstructured":"Bayer O, Adrion C, Al Tawil A et al (2019) Results and lessons learnt from a randomized controlled trial: prophylactic treatment of vestibular migraine with Metoprolol (PROVEMIG). Trials 20:813","journal-title":"Trials"},{"key":"2243_CR18","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1001\/jamaneurol.2025.1006","volume":"82","author":"JP Staab","year":"2025","unstructured":"Staab JP, Eggers SDZ, Jen JC et al (2025) Rizatriptan vs placebo for attacks of vestibular migraine: A randomized clinical trial. JAMA Neurol 82:676\u2013686","journal-title":"JAMA Neurol"},{"key":"2243_CR19","doi-asserted-by":"publisher","first-page":"333102423122397","DOI":"10.1177\/03331024231223971","volume":"44","author":"SM Rahman","year":"2024","unstructured":"Rahman SM, Luebke AE (2024) Calcitonin gene-related peptide receptor antagonism reduces motion sickness indicators in mouse migraine models. Cephalalgia 44:3331024231223971","journal-title":"Cephalalgia"},{"key":"2243_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s10194-022-01403-1","volume":"23","author":"R Tian","year":"2022","unstructured":"Tian R, Zhang Y, Pan Q et al (2022) Calcitonin gene-related peptide receptor antagonist BIBN4096BS regulates synaptic transmission in the vestibular nucleus and improves vestibular function via PKC\/ERK\/CREB pathway in an experimental chronic migraine rat model. J Headache Pain 23:35","journal-title":"J Headache Pain"},{"key":"2243_CR21","doi-asserted-by":"publisher","first-page":"799002","DOI":"10.3389\/fneur.2021.799002","volume":"12","author":"JL Hoskin","year":"2021","unstructured":"Hoskin JL, Fife TD (2021) New Anti-CGRP medications in the treatment of vestibular migraine. Front Neurol 12:799002","journal-title":"Front Neurol"},{"key":"2243_CR22","doi-asserted-by":"publisher","first-page":"333102423116180","DOI":"10.1177\/03331024231161809","volume":"43","author":"CV Russo","year":"2023","unstructured":"Russo CV, Sacc\u00e0 F, Braca S et al (2023) Anti-calcitonin gene-related peptide monoclonal antibodies for the treatment of vestibular migraine: A prospective observational cohort study. Cephalalgia 43:3331024231161809","journal-title":"Cephalalgia"},{"key":"2243_CR23","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1111\/head.14835","volume":"64","author":"JD Sharon","year":"2024","unstructured":"Sharon JD, Krauter R, Chae R et al (2024) A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: the INVESTMENT study. Headache 64:1264\u20131272","journal-title":"Headache"},{"key":"2243_CR24","doi-asserted-by":"publisher","first-page":"944001","DOI":"10.3389\/fneur.2022.944001","volume":"13","author":"S Shi","year":"2022","unstructured":"Shi S, Wang D, Ren T et al (2022) Auditory manifestations of vestibular migraine. Front Neurol 13:944001","journal-title":"Front Neurol"},{"key":"2243_CR25","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S1474-4422(23)00126-6","volume":"22","author":"S Yu","year":"2023","unstructured":"Yu S, Kim BK, Guo A et al (2023) Safety and efficacy of Rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South korea: a phase 3, double-blind, randomised, placebo-controlled trial. Lancet Neurol 22:476\u2013484","journal-title":"Lancet Neurol"},{"key":"2243_CR26","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/00129492-200205000-00024","volume":"23","author":"MD Reploeg","year":"2002","unstructured":"Reploeg MD, Goebel JA (2002) Migraine-associated dizziness: patient characteristics and management options. Otol Neurotol 23:364\u2013371","journal-title":"Otol Neurotol"},{"key":"2243_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/lary.25445","volume":"126","author":"M Salviz","year":"2016","unstructured":"Salviz M, Yuce T, Acar H et al (2016) Propranolol and Venlafaxine for vestibular migraine prophylaxis: A randomized controlled trial. Laryngoscope 126:169\u2013174","journal-title":"Laryngoscope"},{"key":"2243_CR28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/MAO.0000000000000596","volume":"36","author":"A Van Ombergen","year":"2015","unstructured":"Van Ombergen A, Van Rompaey V, Van de Heyning P et al (2015) Vestibular migraine in an otolaryngology clinic: prevalence, associated symptoms, and prophylactic medication effectiveness. Otol Neurotol 36:133\u2013138","journal-title":"Otol Neurotol"},{"key":"2243_CR29","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1177\/0333102409353617","volume":"30","author":"A Bisdorff","year":"2010","unstructured":"Bisdorff A, Andr\u00e9e C, Vaillant M et al (2010) Headache-associated Dizziness in a headache population: prevalence and impact. Cephalalgia 30:815\u2013820","journal-title":"Cephalalgia"},{"key":"2243_CR30","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3389\/fneur.2017.00524","volume":"8","author":"F Liu","year":"2017","unstructured":"Liu F, Ma T, Che X et al (2017) The efficacy of Venlafaxine, Flunarizine, and valproic acid in the prophylaxis of vestibular migraine. Front Neurol 8:524","journal-title":"Front Neurol"},{"key":"2243_CR31","doi-asserted-by":"publisher","first-page":"4147","DOI":"10.57187\/s.4147","volume":"155","author":"SCA Hegemann","year":"2025","unstructured":"Hegemann SCA, Schell A (2025) Treating Meni\u00e8re\u2019s disease with Rimegepant. Swiss Med Wkly 155:4147","journal-title":"Swiss Med Wkly"},{"key":"2243_CR32","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s40263-023-01037-0","volume":"37","author":"JJ Chen","year":"2023","unstructured":"Chen JJ, Zeng BS, Su KP et al (2023) Network Meta-analysis of different treatments for vestibular migraine. CNS Drugs 37:837\u2013847","journal-title":"CNS Drugs"},{"key":"2243_CR33","doi-asserted-by":"publisher","first-page":"1332973","DOI":"10.3389\/fphar.2023.1332973","volume":"14","author":"H Chu","year":"2023","unstructured":"Chu H, Wang Y, Ling X et al (2023) Prophylactic treatments for vestibular migraine: a systematic review and network meta-analysis of randomized clinical trials. Front Pharmacol 14:1332973","journal-title":"Front Pharmacol"},{"key":"2243_CR34","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1001\/archotol.1990.01870040046011","volume":"116","author":"GP Jacobson","year":"1990","unstructured":"Jacobson GP, Newman CW (1990) The development of the Dizziness handicap inventory. Arch Otolaryngol Head Neck Surg 116:424\u2013427","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"2243_CR35","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1472-6815-8-2","volume":"8","author":"K Wilhelmsen","year":"2008","unstructured":"Wilhelmsen K, Strand LI, Nordahl SHG et al (2008) Psychometric properties of the vertigo symptom scale - Short form. BMC Ear Nose Throat Disord 8:2","journal-title":"BMC Ear Nose Throat Disord"},{"key":"2243_CR36","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JB et al (2006) A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 166:1092\u20131097","journal-title":"Arch Intern Med"},{"key":"2243_CR37","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16:606\u2013613","journal-title":"J Gen Intern Med"},{"key":"2243_CR38","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1136\/jnnp-2014-307601","volume":"86","author":"C Lahmann","year":"2015","unstructured":"Lahmann C, Henningsen P, Brandt T et al (2015) Psychiatric comorbidity and psychosocial impairment among patients with vertigo and Dizziness. J Neurol Neurosurg Psychiatry 86:302\u2013308","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2243_CR39","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1023\/A:1026119331193","volume":"12","author":"M Kosinski","year":"2003","unstructured":"Kosinski M, Bayliss MS, Bjorner JB et al (2003) A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res 12:963\u2013974","journal-title":"Qual Life Res"},{"key":"2243_CR40","doi-asserted-by":"publisher","first-page":"M28","DOI":"10.1093\/gerona\/50A.1.M28","volume":"50a","author":"LE Powell","year":"1995","unstructured":"Powell LE, Myers AM (1995) The Activities-specific balance confidence (ABC) scale. J Gerontol Biol Sci Med Sci 50a:M28\u201334","journal-title":"J Gerontol Biol Sci Med Sci"},{"key":"2243_CR41","doi-asserted-by":"crossref","unstructured":"Rahman SM, Hauser C, Faucher S et al (2024) A vestibular challenge combined with calcitonin gene-related peptide (CGRP) promotes Anxiety-Like behaviors. eNeuro 11","DOI":"10.1523\/ENEURO.0270-23.2024"},{"key":"2243_CR42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1152\/jn.00226.2024","volume":"134","author":"SM Rahman","year":"2025","unstructured":"Rahman SM, Faucher S, Jonnala R et al (2025) Systemic calcitonin gene-related peptide modifies auditory and vestibular end organ electrical potentials, and increases sensory hypersensitivities. J Neurophysiol 134:107\u2013117","journal-title":"J Neurophysiol"},{"key":"2243_CR43","doi-asserted-by":"publisher","first-page":"499","DOI":"10.2478\/v10181-012-0077-4","volume":"15","author":"A Dudek","year":"2012","unstructured":"Dudek A, Sienkiewicz W, Kaleczyc J (2012) Immunohistochemical characterization of neurons in the vestibular ganglion (Scarpa\u2019s ganglion) of the pig. Pol J Vet Sci 15:499\u2013507","journal-title":"Pol J Vet Sci"},{"key":"2243_CR44","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1177\/0333102418756863","volume":"39","author":"PR Holland","year":"2019","unstructured":"Holland PR, Saengjaroentham C, Vila-Pueyo M (2019) The role of the brainstem in migraine: potential brainstem effects of CGRP and CGRP receptor activation in animal models. Cephalalgia 39:390\u2013402","journal-title":"Cephalalgia"},{"key":"2243_CR45","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/head.14866","volume":"65","author":"A Sharifi","year":"2025","unstructured":"Sharifi A, Kouhi A, Steenerson KK et al (2025) Vestibular migraine patient assessment tool and handicap inventory (VM-PATHI): A narrative review. Headache 65:521\u2013526","journal-title":"Headache"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-025-02243-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-025-02243-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-025-02243-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T21:03:57Z","timestamp":1767042237000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10194-025-02243-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2243"],"URL":"https:\/\/doi.org\/10.1186\/s10194-025-02243-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8009385\/v1","asserted-by":"object"}]},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"2 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written informed consent prior to enrollment. They were notified that deidentified study-related data would be used in compliance with local regulations on privacy and data protection. The study protocol received approval from the Ethics Committee of Sir Run Run Shaw Hospital and The Second Affiliated Hospital, Zhejiang University School of Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"289"}}